Clinical Trial Update: A Two-Stage Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics and Immunogenicity of Various Doses of Levilimab When Administered Intravenously and Subcutaneously to Healthy Subjects and Subjects With Active Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

Phase 3 two-stage study assessing various doses of levilimab (IV and SC) in healthy subjects and active rheumatoid arthritis patients; currently ACTIVE_NOT_RECR…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Levilimab (levilimab)

Snippet

Sponsor: Biocad | Conditions: Rheumatoid Arthritis | Phase 3 | Status: ACTIVE_NOT_RECRUITING